Use of Synthetic Mucus to Reduce Inflammation in Inflammatory Bowel Disease (IBD)
Improving gut barrier function and reducing intestinal permeability Administer ultra-high molecular weight polymers as synthetic mucus to reduce microbes contact with epithelium
Dissociated Glucocorticoids With Improved Effects in Skeletal Muscle
Two novel glucocorticoids with reduced side effects Used to treat various inflammatory and autoimmune conditions effectively One of the compounds shows promise in treating cachexia
REV-ERB Agonists
Treatment of TH17-mediated autoimmune and inflammatory disorders MS, psoriasis, IBD In vivo testing in EAE and psoriasis models Pre-clinical candidate selection